Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative AVTX - Avalo Therapeutics, Inc.
10.3 M
LAST VALUE
-35.37%
2 YEAR CAGR
-11.71%
5 YEAR CAGR
9.86%
10 YEAR CAGR